Jill is WCG’s Chief Innovation Officer, challenging everything from the way WCG operates internally to how we provide services to our clients. She works across the entire organization to help identify, share and scale the best ideas. Additionally, part of the WCG Transformation team’s remit is to research and explore new technologies, processes, and value for customers.

She brings deep experience across strategy, investing, and building new solutions and technologies for clinical research. Throughout her tenured career, she has created new processes, solutions, and technology platforms for clinical research in collaboration with many sponsors, CROs, for Phase I-IV clinical trials while working for WCG, LabCorp Drug Development (fka Covance), and Veeva Systems.